114 related articles for article (PubMed ID: 1342949)
1. Expression of members of the chromogranin family in primary neuroblastomas.
Pagani A; Forni M; Tonini GP; Papotti M; Bussolati G
Diagn Mol Pathol; 1992 Mar; 1(1):16-24. PubMed ID: 1342949
[TBL] [Abstract][Full Text] [Related]
2. Secretogranin II expression in Ewing's sarcomas and primitive neuroectodermal tumors.
Pagani A; Fischer-Colbrie R; Sanfilippo B; Winkler H; Cerrato M; Bussolati G
Diagn Mol Pathol; 1992 Sep; 1(3):165-72. PubMed ID: 1342962
[TBL] [Abstract][Full Text] [Related]
3. Chromogranin A, chromogranin B and secretogranin II mRNAs in the pituitary and adrenal glands of various mammals. Regulation of chromogranin A, chromogranin B and secretogranin II mRNA levels by estrogen.
Lloyd RV; Hawkins K; Jin L; Kulig E; Fields K
Lab Invest; 1992 Sep; 67(3):394-404. PubMed ID: 1405495
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine differentiation in Ewing's sarcomas and primitive neuroectodermal tumors revealed by reverse transcriptase-polymerase chain reaction of chromogranin mRNA.
Pagani A; Macrí L; Rosolen A; Toffolatti L; Stella A; Bussolati G
Diagn Mol Pathol; 1998 Feb; 7(1):36-43. PubMed ID: 9646033
[TBL] [Abstract][Full Text] [Related]
5. Levels and molecular forms of chromogranins in human childhood neuroblastomas and ganglioneuromas.
Eder U; Fischer-Colbrie R; Kogner P; Leitner B; Bjellerup P; Winkler H
Neurosci Lett; 1998 Aug; 253(1):17-20. PubMed ID: 9754794
[TBL] [Abstract][Full Text] [Related]
6. Estradiol negatively regulates secretogranin II and chromogranin A messenger ribonucleic acid levels in the female rat pituitary but not in the adrenal.
Anouar Y; Benie T; De Monti M; Counis R; Duval J
Endocrinology; 1991 Nov; 129(5):2393-9. PubMed ID: 1935773
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical localization of chromogranin A and secretogranin II in female rat gonadotropes.
Watanabe T; Azuma T; Banno T; Jeziorowski T; Ohsawa Y; Waguri S; Grube D; Uchiyama Y
Arch Histol Cytol; 1998 May; 61(2):99-113. PubMed ID: 9650885
[TBL] [Abstract][Full Text] [Related]
8. Differential increases in chromogranins, but not synapsin I, in cortical neurons following spreading depression: implications for functional roles and transmitter peptide release.
Shen PJ; Gundlach AL
Eur J Neurosci; 1998 Jul; 10(7):2217-30. PubMed ID: 9749750
[TBL] [Abstract][Full Text] [Related]
9. Immunolocalization of secretogranin II, chromogranin A, and chromogranin B in differentiating human neuroblastoma cells.
Giudici AM; Sher E; Pelagi M; Clementi F; Zanini A
Eur J Cell Biol; 1992 Aug; 58(2):383-9. PubMed ID: 1425774
[TBL] [Abstract][Full Text] [Related]
10. Molecular approaches for the analysis of chromogranins and secretogranins.
Lloyd RV; Jin L; Kulig E; Fields K
Diagn Mol Pathol; 1992 Mar; 1(1):2-15. PubMed ID: 1342950
[TBL] [Abstract][Full Text] [Related]
11. Regulation of chromogranin biosynthesis by neurotrophic growth factors in neuroblastoma cells.
Weiss C; Winkler H; Laslop A
Neurochem Int; 2001 Jan; 38(1):43-52. PubMed ID: 10913687
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of secretogranin II and chromogranin A genes in the female rat pituitary through sexual maturation and estrous cycle.
Anouar Y; Duval J
Endocrinology; 1991 Mar; 128(3):1374-80. PubMed ID: 1999159
[TBL] [Abstract][Full Text] [Related]
13. Analysis of chromogranin/secretogranin messenger RNAs in human pituitary adenomas.
Lloyd RV; Jin L
Diagn Mol Pathol; 1994 Mar; 3(1):38-45. PubMed ID: 8162254
[TBL] [Abstract][Full Text] [Related]
14. Chromogranin A and B and secretogranin II in prostatic adenocarcinomas: neuroendocrine expression in patients untreated and treated with androgen deprivation therapy.
Pruneri G; Galli S; Rossi RS; Roncalli M; Coggi G; Ferrari A; Simonato A; Siccardi AG; Carboni N; Buffa R
Prostate; 1998 Feb; 34(2):113-20. PubMed ID: 9465942
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of chromogranin A, chromogranin B and secretogranin II in rat brain by phencyclidine treatment.
Marksteiner J; Weiss U; Weis C; Laslop A; Fischer-Colbrie R; Humpel C; Feldon J; Fleischhacker WW
Neuroscience; 2001; 104(2):325-33. PubMed ID: 11377837
[TBL] [Abstract][Full Text] [Related]
16. Chromogranin gene expressions in colorectal adenocarcinomas.
Pagani A; Papotti M; Abbona GC; Bussolati G
Mod Pathol; 1995 Aug; 8(6):626-32. PubMed ID: 8532695
[TBL] [Abstract][Full Text] [Related]
17. Detection of chromogranins A and B in endocrine tissues with radioactive and biotinylated oligonucleotide probes.
Lloyd RV; Jin L; Fields K
Am J Surg Pathol; 1990 Jan; 14(1):35-43. PubMed ID: 2294779
[TBL] [Abstract][Full Text] [Related]
18. In situ hybridization analysis of chromogranin A and B mRNAs in neuroendocrine tumors with digoxigenin-labeled oligonucleotide probe cocktails.
Lloyd RV; Jin L
Diagn Mol Pathol; 1995 Jun; 4(2):143-51. PubMed ID: 7551295
[TBL] [Abstract][Full Text] [Related]
19. Direct estradiol down-regulation of secretogranin II and chromogranin A mRNA levels in rat pituitary cells.
Anouar Y; Duval J
Mol Cell Endocrinol; 1992 Oct; 88(1-3):97-104. PubMed ID: 1281127
[TBL] [Abstract][Full Text] [Related]
20. In situ hybridization histochemistry of mRNAs for hormones and chromogranins in normal pituitary tissue and pituitary adenoma.
Kilár F; Muhr C; Funa K
Acta Endocrinol (Copenh); 1991 Dec; 125(6):628-36. PubMed ID: 1789058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]